The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.103%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 17th Jul 2014 11:07

Antofagasta: Canaccord Genuity cuts target price from 870p to 835p and maintains a hold recommendation.African Minerals: Canaccord Genuity reduces target price from 230p to 170p and keeps a buy recommendation.Ashmore Group: Goldman Sachs downgrades to neutral with a target price of 430p.Barclays: Exane reduces target price from 280p to 225p retaining a neutral rating.BHP Billiton: Goldman Sachs lowers target price from 1820p to 1810p retaining its neutral rating. Canaccord Genuity reduces target price from 2100p to 1935p and keeps a hold recommendation.Big Yellow Group: Morgan Stanley raises target price from 445p to 615p and upgrades from equal-weight to overweight.Central Asia Mining: Canaccord Genuity lowers target price from 200p to 190p retaining its buy recommendation.City of London Investment Group: N+1 Singer raises target price from 220p to 317p and upgrades to buy.Croda International: Barclays reduces target price from 2330p to 2100p and downgrades from equal-weight to underweight.Diageo: JP Morgan cuts target price from 1780p to 1760p and downgrades from neutral to underweight.Drax Group: Citi cuts target price from 750p to 700p downgrading from buy to neutral.EMIS: Panmure Gordon moves target price from 851p to 858p keeping a buy recommendation. N+1 Singer moves target price from 820p to 830p and retains a buy recommendation.International Ferro Metal: Numis places both its target price and its buy recommendation under review.Fesnillo: Deutsche Bank takes target price from 870p to 890p and maintains a hold recommendation. JP Morgan ups target price from 1030p to 1100p and retains an overweight rating.Friends Life Group: Berenberg ups target price from 310p to 330p and keeps a hold recommendation.Gable Holdings: Panmure Gordon moves target from 92p to 105p and retains a buy recommendation.Genel Energy: Canaccord Genuity reduces target price from 1230p to 1100p, while its buy recommendation remains kept.Glencore Xstrata: Goldman Sachs shifts target price from 295p to 300p and stays with its neutral rating.Greene King: JP Morgan reduces target price from 940p to 890p leaving its neutral rating unaltered.Gulf Keystone: Canaccord Genuity shifts target price from 95p to 100p and keeps a hold recommendation.Hikma Pharmaceuticals: UBS raises target price from 1700p to 2000p and upgrades from neutral to buy.Hilton Food Group: Numis cuts target price from 610p to 592p and retains an add rating.ICAP: UBS lowers target price from 330p to 320p and keeps a sell recommendation. Citi cuts target price from 385p to 370p and leaves its neutral rating unchanged.ITV: Investec places both its target price (prev.: 195p) and its hold recommendation under review.Judges Scientific: WH Ireland reduces target price from 2370p to 1550p and stays with its neutral rating.Kazakhmys: Canaccord Genuity shifts target price from 260p to 265p, while downgrading from hold to sell.Lancashire: JP Morgan cuts target price from 744p to 725p and stays with its neutral rating.Oxford Instruments: N+1 Singer reduces target price from 1445p to 1350p and maintains a hold recommendation.Phoenix Group Holdings: Berenberg upgrades from hold to buy with a target price of 750p.Rexam: Deutsche Bank ups target price from 550p to 570p, while downgrading from buy to hold.Ricardo: Oriel places both its target price (prev.: 670p) and its reduce rating under review.Rio Tinto: Goldman Sachs lowers target price from 2530p to 2520p reiterating its strong sell recommendation. JP Morgan ups target price from 4100p to 4150p and stays with its overweight rating. Canaccord Genuity cuts target price from 4200p to 4145p and reiterates a buy recommendation.Royal Mail: Deutsche Bank reduces target price from 587p to 486p and retains a hold recommendation. JP Morgan cuts target price from 765p to 745p and stays with an overweight rating.Thomas Cook Group: Numis reduces target price from 175p to 135p and maintains its hold recommendation.Trinity Exploration & Production: Investec places its target price (prev.: 250p) under review, while keeping a buy recommendation.Tullow Oil: Canaccord Genuity reduces target price from 950p to 850p and stays with its hold recommendation.Weatherly International: Canaccord Genuity lowers target price from 6p to 5p and keeps its buy recommendation.
More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.